InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the complete record of transactions filed by Russell Angus C., 董事. Director active across 3 companies, notably Revance Therapeutics, Inc.. Cumulatively, 9 disclosures have been published. Split: 1 buy · 0 sell. Total volume traded: €89k. Activity tracked since 5 May 2021. The latest transaction was disclosed on 4 February 2025 (U). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Russell Angus C.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报9 总计
36,506 股@ US$3.6542.0% 占其流量Common StockSEC:0000950170-25-015322:0
15,000 股0Common StockSEC:0001479290-24-000089:0
3,534 股0Common StockSEC:0001479290-23-000060:0
1,984 股Common StockSEC:0001209191-22-046966:0
6,059 股0Common StockSEC:0001479290-22-000059:0
6,400 股@ US$15.740840.8% 占其流量Common StockSEC:0001479290-21-000173:0
标准退出：2022年3月13日 (T+90)
96,864 股Common StockSEC:0001387131-21-008440:0
24,720 股@ US$2.20100.0% 占其流量Common Shares, no par valueSEC:0001493152-21-015786:0
4,013 股0Common StockSEC:0001479290-21-000114:0
9 条申报中的 9 条
About Russell Angus C.
Angus C. Russell serves as a Board Member at Revance Therapeutics, Inc., Lineage Cell Therapeutics, Inc., and TherapeuticsMD, Inc. He plays a key role in the governance of these companies, bringing his expertise in strategy and sustainability. His commitment to innovation and operational efficiency is essential for the success of the boards.
